Clinical Trials Logo

Ovulation; Failure or Lack of clinical trials

View clinical trials related to Ovulation; Failure or Lack of.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04060992 Not yet recruiting - Clinical trials for Ovulation; Failure or Lack of

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is twofold: First, to see if elagolix can suppress gonadotropin and ovarian hormones in the short-term period, when only administered for a 72-hour period. If elagolix effectively suppresses gonadotropin and ovarian hormones in a timely manner, it could be used to alter aspects of the menstrual cycle, depending on when administered. Second, is there a window for when elagolix functions best? While other studies initiate elagolix at the start of a woman's menstrual cycle, investigators of this study want to determine if administering elagolix at various points in a woman's menstrual cycle alters its ability to suppress gonadal and ovarian hormones.